Diffusion Pharmaceuticals Inc (NASDAQ:DFFN)
| 0.4002 Delayed Data As of 3:58pm ET |  +0.0112 / +2.88%Today’s Change | 0.34 Today|||52-Week Range 1.85 | -49.66% Year-to-Date |
Latest DFFN News | Press Releases
No recent news for Diffusion Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.39 |
| Today’s open | 0.37 |
| Day’s range | 0.37 - 0.41 |
| Volume | 35,640 |
| Average volume (3 months) | 1,253,127 |
| Market cap | $38.3M |
Data as of 3:58pm ET, 12/08/2021
Growth & Valuation
| Earnings growth (last year) | +82.97% |
| Earnings growth (this year) | +40.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NERVMinerva Neuroscience... | +0.03 | +3.07% |
| --Herantis Pharma Oyj | 0.00 | 0.00% |
| NRBONeurobo Pharmaceutic... | +0.06 | +4.14% |
| APDNApplied DNA Sciences... | +0.14 | +2.71% |
Data as of 3:59pm ET, 12/08/2021
Financials
| Next reporting date | March 30, 2022 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$14.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Charlottesville, Virginia |
Forecasts
